Gender differences in cardiovascular risk, treatment, and outcomes: a post-hoc analysis from the REWIND trial

被引：0
|
作者：
Ferrannini, G. [1 ]
Maldonado, J. M. [2 ]
Raha, S. [2 ]
Rao-Melacini, P. [3 ]
Khatun, R. [3 ]
Atisso, C. [2 ]
Shurzinske, L. [2 ]
Gerstein, H. [3 ]
Ryden, L. [1 ]
Bethel, M. A. [2 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Populat Hlth Res Inst, Hamilton, ON, Canada
来源：
DIABETOLOGIA | 2021年 / 64卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5
引用
收藏
页码：4 / 5
页数：2
相关论文
共 50 条
  • [1] Gender differences in cardiovascular risk, treatment, and outcomes: a post hoc analysis from the REWIND trial
    Ferrannini, Giulia
    Maldonado, Juan M.
    Raha, Sohini
    Rao-Melacini, Purnima
    Khatun, Rutaba
    Atisso, Charles
    Shurzinske, Linda
    Gerstein, Hertzel C.
    Ryden, Lars
    Bethel, M. Angelyn
    [J]. SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2023, 57 (01)
  • [2] Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: A post-hoc analysis from the REWIND randomized trial
    Branch, Kelley
    Dagenais, G.
    Avezum, A.
    Basile, J.
    Conget, I.
    Cushman, W. C.
    Jansky, P.
    Lakshmanan, M.
    Lanas, F.
    Leitner, L. A.
    Pais, P.
    Pogosova, N.
    Raubenheimer, P. J.
    Gerstein, H.
    Probstfield, J.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 158 - 159
  • [3] Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial
    Branch, Kelley R. H.
    Dagenais, Gilles R.
    Avezum, Alvaro
    Basile, Jan
    Conget, Ignacio
    Cushman, William C.
    Jansky, Petr
    Lakshmanan, Mark
    Lanas, Fernando
    Leiter, Lawrence A.
    Pais, Prem
    Pogosova, Nana
    Raubenheimer, Peter J.
    Ryden, Lars
    Shaw, Jonathan E.
    Sheu, Wayne H-H
    Temelkova-Kurktschiev, Theodora
    Bethel, M. Angelyn
    Gerstein, Hertzel C.
    Chinthanie, Ramasundarahettige
    Probstfield, Jeffrey L.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1805 - 1812
  • [4] Letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial
    Ferreira, Joao Pedro
    Neves, Joao Sergio
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (11)
  • [5] Burden of Cardiovascular or Fatal Outcomes in People With Type 2 Diabetes and Cardiovascular Risk Factors Treated With Dulaglutide a Post Hoc Analysis From the Rewind Trial
    Dagenais, Gilles
    Lakshmanan, Mark C.
    Dyal, Leanne
    Atisso, Charles Messan
    Colhoun, Helen
    Ryden, Lars E.
    Gerstein, Hertzel C.
    [J]. CIRCULATION, 2020, 142
  • [6] Reply to the letter regarding the article 'Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial'
    Branch, Kelley R. H.
    Gerstein, Hertzel C.
    Probstfield, Jeffrey L.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (11) : 2207 - 2208
  • [7] Does dulaglutide impact a composite outcome reflecting atherosclerosis? A post-hoc analysis of the REWIND trial
    Ferrannini, G.
    Mellbin, L.
    Kirabo, F.
    Ramasundarahettige, C.
    Herstein, H. G.
    Ryden, L.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 2400 - 2400
  • [8] Cardiovascular Risk in Patients With Symptomatic Intracranial Atherosclerosis: A Post-Hoc Analysis of the SAMMPRIS Trial
    Yaghi, Shadi
    de Havenon, Adam
    Scher, Erica
    Chang, Andrew
    Kvernland, Alexandra
    Dehkharghani, Seena
    Rostanski, Sara
    Ishida, Koto
    Torres, Jose
    Fernanine, George
    Merkler, Alexander
    Mac Grory, Brian
    Burton, Tina
    Cutting, Shawna
    Furie, Karen
    [J]. STROKE, 2020, 51
  • [9] Febuxostat and renal outcomes: post-hoc analysis of a randomized trial
    Kohagura, Kentaro
    Kojima, Sunao
    Uchiyama, Kazuaki
    Yokota, Naoto
    Tokutake, Eiichi
    Wakasa, Yutaka
    Hiramitsu, Shinya
    Waki, Masako
    Jinnouchi, Hideaki
    Kakuda, Hirokazu
    Hayashi, Takahiro
    Kawai, Naoki
    Sugawara, Masahiro
    Mori, Hisao
    Tsujita, Kenichi
    Matsui, Kunihiko
    Hisatome, Ichiro
    Ohya, Yusuke
    Kimura, Kazuo
    Saito, Yoshihiko
    Ogawa, Hisao
    [J]. HYPERTENSION RESEARCH, 2023, 46 (06) : 1417 - 1422
  • [10] Febuxostat and renal outcomes: post-hoc analysis of a randomized trial
    Kentaro Kohagura
    Sunao Kojima
    Kazuaki Uchiyama
    Naoto Yokota
    Eiichi Tokutake
    Yutaka Wakasa
    Shinya Hiramitsu
    Masako Waki
    Hideaki Jinnouchi
    Hirokazu Kakuda
    Takahiro Hayashi
    Naoki Kawai
    Masahiro Sugawara
    Hisao Mori
    Kenichi Tsujita
    Kunihiko Matsui
    Ichiro Hisatome
    Yusuke Ohya
    Kazuo Kimura
    Yoshihiko Saito
    Hisao Ogawa
    [J]. Hypertension Research, 2023, 46 : 1417 - 1422
12345